Evidence map›Paper›PMID 15178767›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos.

Ayala Luria, J David Furlow

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The retinoid X receptors and their ligands.Biochimica et biophysica acta · 2012
    Review
  5. Article
  6. Article
  7. Article
  8. Transgenesis procedures in Xenopus.Biology of the cell · 2008
    Review
  9. Locust retinoid X receptors: 9-Cis-retinoic acid in embryos from a primitive insect.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ayala LuriaSection of Neurobiology, Physiology, and Behavior, University of California, Davis, CA 95616-8519, USA.
J David Furlow
University of California, Davis · US

Funding

THYROID HORMONE CONTROL OF A GENE EXPRESSION NETWORKR01DK055511 · NIDDK · UNIVERSITY OF CALIFORNIA DAVIS · PI FURLOW, JOHN DAVID · 1999 to 2008
$1.2M
NIDDK NIH HHS DK55511NIDDK NIH HHS R01 DK055511
6 · The paper itself

Abstract

Most studies on the nuclear retinoid-X receptor (RXR) have focused on its role as a heterodimeric partner but less about its own activation pattern during development and the distribution of potential endogenous ligands. The aim of this study is to visualize the distribution of activated RXRalpha in live transgenic Xenopus laevis embryos across a wide range of developmental stages. We adopted a nuclear receptor-Gal4 fusion/upstream activation sequence-based reporter system for our assay. Strong activation of the RXRalpha ligand-binding domain was observed in a segment of the spinal cord just posterior to the hindbrain. This activation is first detected in neurula stage embryos and persists up to swimming tadpole stages, after which activation strongly declines. Addition of exogenous ligands, such as 9-cis retinoic acid or all-trans retinoic acid, expands the activation of RXR throughout the spinal cord but not in the brain, whereas the RXR-specific ligand LG268 expanded the Gal4-RXR activation into the brain and olfactory epithelia. Treatment with the RAR-specific ligand 4-(E-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid or thyroid hormone had no effect on Gal4-RXR activation, whereas these compounds significantly increased their corresponding Gal4/receptor fusion proteins under similar conditions. Embryos expressing a Gal4-RXR fusion protein with a deletion in the ligand-dependent activation domain (AF2) show no reporter gene activation. The results shown in this paper reveal a specific activation pattern for Gal4-RXRalpha specifically in the developing spinal cord and suggest the existence of RXR ligand "hot-spots" in this region.

Indexed as

AnimalsAnimals, Genetically ModifiedAnticholesteremic AgentsBenzoatesDNA-Binding ProteinsGene Expression Regulation, DevelopmentalGenes, ReporterLigandsNicotinic AcidsOrganic ChemicalsReceptors, Retinoic AcidRecombinant Fusion ProteinsRetinoidsRetinoid X ReceptorsSaccharomyces cerevisiae ProteinsSpinal Cord4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acidAnticholesteremic AgentsBenzoatesDNA-Binding ProteinsGAL4 protein, S cerevisiaeLG 100268LG 268LigandsNicotinic AcidsOrganic ChemicalsReceptors, Retinoic AcidRecombinant Fusion ProteinsRetinoidsRetinoid X ReceptorsSaccharomyces cerevisiae ProteinsTetrahydronaphthalenesTranscription FactorsTretinoin

Identifiers

PMID15178767
PMCPMC428459
OpenAlexW2015562304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.